Nicolas Garnier joins Servier as chief patient officer

French independent pharma major Servier today announced the appointment of Nicolas Garnier as chief patient officer, effective from December 4. He takes over from Bertrand Renaud, who will retire at the end of January 2024.

Reporting to Arnaud Lallouette, executive vice president global medical and patient affairs, Mr Garnier leads Global Patient Affairs department, whose mission is to integrate the voice of the patient at each stage of the drug lifecycle. His main objective is to coordinate, promote and develop patient engagement among all group employees and global subsidiaries, working closely with patients and the organizations that represent them. By doing this, Mr Garnier will continue the key work begun by Mr Renaud which aimed at reinforcing the patient culture within the Group and the dynamic of working collaboratively with patients and their organizations. T

Mr Garnier began his professional career in 2015 as a medical advisor in the Rare Disease unit at the Canadian subsidiary of US pharma giant Pfizer (NYSE: PFE). He quickly progressed towards roles that forged his understanding of patients in order to better integrate their voice at each stage of the drug lifecycle. Thus, he created the Pfizer Canada Patient Centricity Council and then in 2019 became director of patient advocacy in the Global Product Development division of Pfizer Rare Disease in the USA.